COMMUNIQUÉS West-GlobeNewswire
-
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
07/07/2026 -
New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
07/07/2026 -
Luxe Treatment Center marks five years of addiction treatment in Las Vegas, surpassing 1,000 patients served
07/07/2026 -
MAPS Publishes Ibogaine Investigator's Brochure as a Free, Open-Access Resource
07/07/2026 -
InStride Health’s New Peer-Reviewed Research Demonstrates Reductions in Caregiver Strain following Specialty Virtual Care for Families of Youth with Anxiety and OCD
07/07/2026 -
PDV MedTech et Corscience annoncent un partenariat stratégique visant à faire progresser le développement et la fabrication de technologies médicales aux États-Unis et en Europe
07/07/2026 -
Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026
07/07/2026 -
Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
07/07/2026 -
SS Innovations Subsidiary SSICRS Graduates Inaugural Cardiac Robotic Surgery Training Class
07/07/2026 -
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1
07/07/2026 -
PDV MedTech and Corscience Announce Strategic Partnership to Advance MedTech Development and Manufacturing Across the US and Europe
07/07/2026 -
Amplia Announces Appointment of Brett Carter to Board
07/07/2026 -
Stipple Bio Appoints Biopharma Business Development Leader Roland Gendron as Chief Business Officer
07/07/2026 -
Oncotelic Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway
07/07/2026 -
Nu-Tek BioSciences Present Cell Nutrient Innovation, Raw Material Expertise at SIMB 2026
07/07/2026 -
Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board
07/07/2026 -
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program
07/07/2026 -
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
07/07/2026 -
Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day
07/07/2026
Pages